Which PGDs Make the Most Money for Pharmacies?

Not all PGDs are created equal when it comes to revenue. The difference between a well-chosen PGD portfolio and a poorly chosen one can be tens of thousands of pounds per year.

The highest-revenue PGD category in UK community pharmacy is travel health. A single travel consultation can generate between £150 and £300 per patient when you factor in multiple vaccinations, anti-malarials, and follow-up doses. The average pharmacy with a well-run travel clinic earns upwards of £46,000 per year from travel services alone.

Weight management is the fastest-growing category. GLP-1 treatments like Wegovy and Mounjaro generate £200–350 per patient per month, with patients typically staying on treatment for 6–12 months. A pharmacy seeing just 10 weight management patients generates £24,000–42,000 annually from this service alone.

Vaccines beyond travel — private flu, shingles (Shingrix), chickenpox, and the newer RSV vaccines — form a strong secondary revenue layer. Shingles vaccination generates £150–200 per two-dose course, and the private market for over-70s is significant since the NHS programme has age caps.

Men's and women's health services generate moderate per-consultation revenue but have high volume and strong repeat rates. Erectile dysfunction and hair loss treatments create loyal, returning patients. HRT initiation is a major emerging opportunity — one in three women in menopause receive no treatment, and pharmacy-based HRT under PGD is virtually uncontested.

Sexual health, particularly PrEP for HIV prevention, represents a growing private market. Thousands of patients currently pay £50+ per month through online clinics — pharmacy-based PrEP under PGD is faster, more accessible, and builds local relationships.

The key to maximising revenue is portfolio breadth combined with smart prioritisation. Launch with high-demand, high-margin services first (travel, weight management, vaccines), then layer in volume-driving services (UTI, ED, skin) that keep footfall high and build patient loyalty.

The critical mistake is limiting your portfolio to what competitors offer. If you only provide the same 20 PGDs as Pharmadoctor, you're competing on price. If you offer 60+ including exclusive services like HRT, TRT, and PrEP, you're competing on access — and winning.